Pain Cloud®

Did you know that over-reliance on non-translatable pre-clinical models contribute to a 99% failure rate in drug development? As a leading B2B platform in pain research, Pain Cloud® utilizes Personalized Analgesics® in-silico network biology research to empower Pharmaceutical and Biotech companies, as well as Contract Research Organizations (CROs), in revolutionizing their approach to drug development and clinical trials. Our innovative technology significantly reduces R&D costs and timelines while enhancing success rates through precise target-to-patient matching, ultimately transforming how pain is treated. Connect with us to discover how Pain Cloud® can optimize your pain research efforts and drive impactful results in drug development and clinical trials. Why Pain Cloud? • Advanced Technology: Pain Cloud® employs cutting-edge Personalized Analgesics® in-silico network biology research to revolutionize pain research and drug development. • Cost Efficiency: By replacing traditional R&D methods, Pain Cloud® significantly reduces research and development costs associated with pain treatments. • Time Savings: The platform accelerates the drug development process, minimizing timelines and expediting the path to market for new pain medications. • Enhanced Success Rates: With precise target-to-patient matching, Pain Cloud® increases the probability of success in clinical trials, leading to more effective pain treatments. • Comprehensive Database: Pain Cloud's® proprietary Pain Landscape® database, containing over 1,000 diseases, allows for precise target identification and patient stratification.